RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $903,000 | -64.1% | 18,816 | -64.8% | 0.02% | +53.3% |
| Q4 2019 | $2,512,000 | +170.4% | 53,530 | +73.3% | 0.02% | +66.7% |
| Q2 2019 | $929,000 | +34.1% | 30,880 | -0.2% | 0.01% | +28.6% |
| Q1 2019 | $693,000 | +1.3% | 30,943 | -17.7% | 0.01% | -12.5% |
| Q4 2018 | $684,000 | -28.9% | 37,602 | -29.3% | 0.01% | -33.3% |
| Q3 2018 | $962,000 | +524.7% | 53,199 | +242.8% | 0.01% | +500.0% |
| Q2 2018 | $154,000 | -7.8% | 15,521 | -20.8% | 0.00% | -33.3% |
| Q4 2017 | $167,000 | -15.2% | 19,592 | +86.6% | 0.00% | -25.0% |
| Q2 2017 | $197,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |